{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:27Z","timestamp":1791474687123,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2019-67021-29858"],"award-info":[{"award-number":["2019-67021-29858"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ijbiomac.2021.12.035","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:40:58Z","timestamp":1639482058000},"page":"506-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A novel combination therapy for multidrug resistant pathogens using chitosan nanoparticles loaded with \u03b2-lactam antibiotics and \u03b2-lactamase inhibitors"],"prefix":"10.1016","volume":"195","author":[{"given":"Peixin","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna J.","family":"Partow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corwin D.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongseon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangcheol C.","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.ijbiomac.2021.12.035_bb0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.15585\/mmwr.mm6432a3","article-title":"CDC grand rounds: getting smart about antibiotics","volume":"64","author":"Demirjian","year":"2015","journal-title":"MMWR-Morbid. Mortal. WklyRep."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/ice.2017.156","article-title":"Incidence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review","volume":"38","author":"McDanel","year":"2017","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0030","first-page":"295","article-title":"Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings","volume":"3","author":"Khanfar","year":"2009","journal-title":"J. Infect. Dev. Countr."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/j.1469-0691.2010.03127.x","article-title":"High prevalence of bla(CTX-M) extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China","volume":"16","author":"Sun","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.03030-18","article-title":"Genomic comparison reveals natural occurrence of clinically relevant multidrug-resistant extended-spectrum-lactamase-producing Escherichia coli strains","volume":"85","author":"Teng","year":"2019","journal-title":"Appl. Environ. Microb."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijfoodmicro.2013.10.006","article-title":"Extended spectrum ss-lactamase- and constitutively AmpC-producing Enterobacteriaceae on fresh produce and in the agricultural environment","volume":"168\u2013169","author":"Blaak","year":"2014","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0050","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3389\/fmicb.2016.01931","article-title":"ESBL-producing Escherichia coli from cows suffering mastitis in China contain clinical Class 1 integrons with CTX-M linked to ISCR1","volume":"7","author":"Ali","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.12.035_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0060","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1093\/jac\/dkaa183","article-title":"Oral cephalosporin and beta-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections","volume":"75","author":"Stewart","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0065","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/AAC.01802-13","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa with various resistance patterns isolated in U.S. Hospitals (2011-2012)","volume":"57","author":"Farrell","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/Tazobactam: a novel cephalosporin\/beta-lactamase inhibitor combination with activity against multidrug-resistant gram-negative Bacilli","volume":"74","author":"Zhanel","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","article-title":"Solid lipid nanoparticles: emerging colloidal nano drug delivery systems","volume":"10","author":"Mishra","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11100524","article-title":"Enhanced treatment effects of Tilmicosin against Staphylococcus aureus cow mastitis by self-assembly sodium alginate-chitosan nanogel","volume":"11","author":"Zhou","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2008.05.020","article-title":"Antibiotic-eluting medical devices for various applications","volume":"130","author":"Zilberman","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0090","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1039\/C7TB02105D","article-title":"Synthesis, coating, and drug-release of hydroxyapatite nanoparticles loaded with antibiotics","volume":"5","author":"Geuli","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0095","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ijbiomac.2018.05.130","article-title":"Fabrication of electrospun poly(vinyl alcohol)\/dextran nanofibers via emulsion process as drug delivery system: kinetics and in vitro release study","volume":"116","author":"Moydeen","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1021\/acs.molpharmaceut.6b00886","article-title":"In vivo drug delivery performance of lipiodol-based emulsion or drug-eluting beads in patients with hepatocellular carcinoma","volume":"14","author":"Lilienberg","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1021\/acs.molpharmaceut.7b00138","article-title":"Comment on \"In vivo drug delivery performance of lipiodol-based emulsion or drug-eluting beads in patients with hepatocellular carcinoma\"","volume":"15","author":"Gonzalez","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0110","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1021\/ie4008858","article-title":"Generation and optimization of palm oil-based oil-in-eater (O\/W) submicron-emulsions and encapsulation of curcumin using a liquid whistle hydrodynamic cavitation reactor (LWHCR)","volume":"52","author":"Parthasarathy","year":"2013","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0115","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.2147\/DDDT.S84486","article-title":"Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite\/poly amino acid loaded with rifapentine microspheres","volume":"9","author":"Yan","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/626589","article-title":"Nanospider technology for the production of nylon-6 nanofibers for biomedical applications","volume":"2011","author":"El-Newehy","year":"2011","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0125","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/acs.langmuir.8b03919","article-title":"Toward the formulation of stable micro and nano double emulsions through a silica coating on internal water droplets","volume":"35","author":"Akram","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(89)90329-3","article-title":"Design and characterization of a submicronized O\/W emulsion of diazepam for parenteral use","volume":"54","author":"Levy","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0135","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1021\/acs.jafc.0c00874","article-title":"Slow-release and nontoxic pickering emulsion platform for antimicrobial peptide","volume":"68","author":"Cai","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.carbpol.2017.08.082","article-title":"Application, mode of action, and in vivo activity of chitosan and its micro and nanoparticles as antimicrobial agents: a review","volume":"176","author":"Ma","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jhazmat.2017.07.071","article-title":"Comprehensive in vitro and in vivo risk assessments of chitosan microparticles using human epithelial cells and Caenorhabditis elegans","volume":"341","author":"Ma","year":"2018","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0150","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1021\/acsami.6b00894","article-title":"Chitosan microparticles exert broad-spectrum antimicrobial activity against antibiotic-resistant micro-organisms without increasing resistance","volume":"8","author":"Ma","year":"2016","journal-title":"ACS Appl. Mater. Int."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092723","article-title":"Underlying mechanism of antimicrobial activity of chitosan microparticles and implications for the treatment of infectious diseases","volume":"9","author":"Jeon","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0160","doi-asserted-by":"crossref","first-page":"47278","DOI":"10.1021\/acsami.0c14313","article-title":"Characterization of the vibriocidal activity of chitosan microparticles: a potential therapeutic agent for emerging multidrug-resistant cholera infections","volume":"12","author":"Weppelmann","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0165","doi-asserted-by":"crossref","first-page":"18332","DOI":"10.1021\/acsami.0c02177","article-title":"Selective killing of shiga toxin-producing Escherichia coli with antibody-conjugated chitosan nanoparticles in the gastrointestinal tract","volume":"12","author":"Ma","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10837459709022631","article-title":"Microencapsulation of antimicrobial ceftiofur drugs","volume":"2","author":"Bodmeier","year":"1997","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.carbpol.2013.02.031","article-title":"Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study","volume":"95","author":"Hosseini","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jiac.2014.08.028","article-title":"In vitro susceptibility of characterized beta-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations","volume":"21","author":"Yoshizumi","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0185","series-title":"Methods for Dilution Antimicrobial Susceptibility Testes for Bacteria That Grow Aerobically; Approved Standard","year":"2012"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0190","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.2147\/IJN.S51469","article-title":"Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach","volume":"8","author":"Tang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0195","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2147\/IJN.S201449","article-title":"Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib","volume":"14","author":"Subongkot","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0200","first-page":"72","article-title":"Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain","volume":"13","author":"Liu","year":"2018","journal-title":"asianJ. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0205","first-page":"418","article-title":"Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo","volume":"12","author":"Sun","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0210","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Illum","year":"1998","journal-title":"Pharm. Res.-Dordr."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ddtec.2005.05.008","article-title":"Chitosan and the mucosal delivery of biotechnology drugs","volume":"2","author":"Issa","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biotechadv.2007.07.009","article-title":"Chitosan and its derivatives for tissue engineering applications","volume":"26","author":"Kim","year":"2008","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijfoodmicro.2010.09.012","article-title":"Antimicrobial properties of chitosan and mode of action: a state of the art review","volume":"144","author":"Kong","year":"2010","journal-title":"Int. J. Food Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.09.016","article-title":"Application of chitosan microparticles for treatment of metritis and in vivo evaluation of broad spectrum antimicrobial activity in cow uteri","volume":"110","author":"Jeon","year":"2016","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.12.035_bb0235","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/AEM.02587-10","article-title":"Reduction of Escherichia coli O157:H7 shedding in cattle by addition of chitosan microparticles to feed","volume":"77","author":"Jeong","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0240","series-title":"CFR - Code of Federal Regulations Title 21","author":"FDA","year":"2019"},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0245","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/acs.jafc.6b04705","article-title":"Gelatin particle-stabilized high-internal phase emulsions for use in oral delivery systems: protection effect and in vitro digestion study","volume":"65","author":"Tan","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0250","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/wnan.1282","article-title":"Nanoparticle approaches against bacterial infections","volume":"6","author":"Gao","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MRM.0b013e3283587727","article-title":"Beta-lactams: chemical structure, mode of action and mechanisms of resistance","volume":"24","author":"Fernandes","year":"2013","journal-title":"Rev. Med. Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40001-020-00418-1","article-title":"A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-beta-lactamases producing bacterial strain: a molecular and biochemical approach","volume":"25","author":"Maryam","year":"2020","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0265","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/fmb-2019-0032","article-title":"Synergistic effect of doripenem in combination with cefoxitin and tetracycline in inhibiting NDM-1 producing bacteria","volume":"14","author":"Maryam","year":"2019","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0270","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1038\/s41598-017-09588-1","article-title":"Potential inhibitors designed against NDM-1 type metallo-beta-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.12.035_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11908-019-0690-9","article-title":"Recognizing and overcoming resistance to new beta-lactam\/beta-lactamase inhibitor combinations","volume":"21","author":"Ho","year":"2019","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"Pt B","key":"10.1016\/j.ijbiomac.2021.12.035_bb0280","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.ijbiomac.2017.08.057","article-title":"Size optimization and in vitro biocompatibility studies of chitosan nanoparticles","volume":"104","author":"Thandapani","year":"2017","journal-title":"Int. J. Biol. Macromol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021026519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021026519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:14:05Z","timestamp":1758878045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021026519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":53,"alternative-id":["S0141813021026519"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.035","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel combination therapy for multidrug resistant pathogens using chitosan nanoparticles loaded with \u03b2-lactam antibiotics and \u03b2-lactamase inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}